Serum Thymidine Kinase 1 Activity as a Pharmacodynamics Marker of Cyclin-Dependent Kinase 4/6 Inhibition in Patients with Early Stage Breast Cancer Receiving Neoadjuvant Palbociclib

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Shana Thomas1, Ning Liu1, Rosy (Jingqin) Luo1, Jeremy Hoog1, Mattias Bergqvist2, Magnus Neumüller2, Edward M. Suh2, Zhanfang Guo1, Kiran Vij1, Souzan Sanati1, Matthew Ellis3, Cynthia X. Ma1 1Washington University School of Medicine, St. Louis, MO, 63110; 2 Biovica International AB, Uppsala, Sweden, 3Baylor College of Medicine, Houston, TX, 77030

Journal title: San Antonio Breast Cancer Symposium, SABCS 2016, Abstract P5-04-02

Journal number: ANNUAL

Journal publisher: San Antonio Breast Cancer Symposium

Published year: 2016